Use of SGLT2 Inhibitors in Dystrophin Deficient Cardiomyopathy: A Multi-center Study Using the ACTION Registry

Pediatric Cardiology · Published 2026-08-01 · DOI 10.1007/s00246-026-04410-0

Free full text

Authors (15)

Rachel E. Harris, Carol A. Wittlieb-Weber, Chet Villa, Paul Esteso, Svetlana Shugh, Emily Hayes, Christopher Knoll, Ashwin K. Lal, Deepa Mokshagundam, Renata Shih, Laura Radel, Elizabeth L. Profita, Aislinn DeSieghardt, Benjamin Kroslowitz, Joseph Spinner

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Harris, R., Wittlieb-Weber, C., Villa, C., et al. (2026). Use of SGLT2 Inhibitors in Dystrophin Deficient Cardiomyopathy: A Multi-center Study Using the ACTION Registry. Pediatric Cardiology. https://doi.org/10.1007/s00246-026-04410-0

Related articles